Clinical Trials and Research
Research at Ramsay
Ramsay is proud to play a leading role in Australia’s health and medical research sector by driving research through the
Ramsay Research & Development Network, the
Ramsay Hospital Research Foundation, and our
Research Ethics, and
Governance Unit.
The Clinical Trials and Research Unit at Joondalup Health Campus is part of the Ramsay Research & Development Network that operates across 20+ Ramsay Health Care facilities throughout Australia. Our hospital actively encourages and supports clinical research as a key contributor to improved patient outcomes. We believe that providing early access to promising clinical trials is essential to delivering high-quality, leading-edge care, consistent with the standard of care at our hospital.
Conducting Research
Participating in Research
Current Trials
Conducting Research
Our hospital has a dedicated clinical trials & research unit that supports the conduct of research across all aspects of the hospital. Our site manager and the broader research team can provide advice on how to get involved.
Contact Clinical Trials and Research Manager via email at
Research.JHC@ramsayhealth.com.au
All research conducted at Joondalup Health Campus requires local endorsement, as well as Ethics & Research Governance Approval. If you are interested in conducting research the following steps will need to be taken:
Step 1. Apply for Research Endorsement
This first step allows the hospital to review the proposed research and ensure that it is appropriate to be conducted at the hospital. This guarantees the researcher has confirmation early that the hospital is able to provide the necessary infrastructure, people or access that will be required and once approved, the research will be established seamlessly.
To apply for Research Endorsement, please use this form.
Once completed, applicants should email this form to
Research.JHC@ramsayhealth.com.au
This form should be completed by Principal Investigators, Students, or nursing and allied health professionals and our internal research teams. Direct submission of this form from CROs or Industry Sponsors will not be accepted.
Step 2: Research Ethics
Ramsay will accept research ethics approvals from any NHMRC endorsed Human Research Ethics Committee, provided that committee is willing to oversee the research in Ramsay.
Ramsay also maintains a Human Research Ethics Committee who can assist where an applicant has not previously sought ethics approval. Further information about Ramsay’s processes can be found here.
Step 3: Research Governance
It is a requirement of Ramsay Health Care that all research applications receive research governance approval prior to any research commencing at the hospital.
Applications for Research Governance can be submitted through the REGGS platform.
Click here to access REGGS
All questions relating to Research Governance can be directed to the following email address:
ResearchGovernance@ramsayhealth.com.au
or call the Ramsay National Research Unit on (02) 9433 3854.
Participating in Research
If you’re interested in participating in a clinical trial, you may be eligible for one currently being conducted at Joondalup Health Campus as listed below. Please speak with your doctor to explore your options. If you’re interested in participating in a clinical trial, not offered at Joondalup Health Campus, your doctor may be able to help you find another trial appropriate for you. Alternatively, you can search for suitable clinical trials through the Australian Clinical Trials website or ClinTrial Refer.
For any inquiries, please contact Clinical Trials and Research Manager via email at Research.JHC@ramsayhealth.com.au
Clinical Trials Joondalup Health Campus
| Therapeutic area |
Study Name |
Recruitment status |
Site Investigator |
| Anaesthetics/Cardiology |
ECHO-NOF III - Look before you leap: How transthoracic ECHOcardiography before Neck Of Femur saves lives in frail older people – The proposed Pragmatic ECHONOF III trial
|
OPEN |
Dr Lisa ZUCCHERELLI |
| Oncology – Non-small cell lung cancer |
KRYSTAL-4 (NCT06875310) -
A Randomized, Double-Blind, Phase 3 Trial of Adagrasib plus Pembrolizumab plus Chemotherapy vs. Placebo plus Pembrolizumab plus Chemotherapy in Participants with Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer with KRAS G12C Mutation
|
OPEN |
Dr Arman HASANI |
| Oncology – Non-small cell lung cancer |
REZLIENT-2 (NCT05967689) -
An Open-Label, Phase 2b, Global Multicenter Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Exon 20 Insertion and Uncommon/Single or Compound Epidermal Growth Factor Receptor Mutations
|
OPEN |
Dr Arman HASANI |
| Oncology – Non-small cell lung cancer |
ROSETTA Lung-201 (NCT07361497) -
ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants With Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy
|
OPEN |
Dr Arman HASANI |
| Oncology – Non-small cell lung cancer |
ROSETTA Lung-202 (NCT07361510) -
A Randomized, Double-Blind, Phase 3 Study of Pumitamig Monotherapy Compared to Pembrolizumab as First-line Treatment in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With PD-L1 ≥ 50%
|
OPEN |
Dr Arman HASANI |
| Paediatrics – Asthma |
ARIA (NCT05757102) -
A Phase 3, 24-week, randomized, double-blind, parallel-group Bayesian Dynamic Borrowing study comparing the efficacy, safety, tolerability and pharmacokinetics of FF/UMEC/VI with FF/VI in 12-17-year-old participants with inadequately controlled asthma on stable maintenance therapy with ICS/LABA
|
OPEN |
Professor Desiree SILVA |
Research Activity
To read more about the research conducted at Joondalup Health Campus, you can download our Annual Research Reports below: